Some Lobbyists Expect CMS To Publish Part B Demo Rule Next Month

By John Wilkerson / August 23, 2016 at 7:11 PM
CMS does not have long to finish the first phase of its proposed Part B drug price demonstration if it wants to stay on schedule to start it this fall, and some lobbyists expect the administration to publish the rule next month. Whenever it's published, lobbyists and consultants expect CMS to make at least some of the changes that congressional Democrats requested, such as strengthening the appeals process and exempting rural providers or drugs without substitutes. Talk on the campaign...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.